| Real solutions for fake news? Measuring the effectiveness of general warnings and fact-check tags in reducing belief in false stories on social media K Clayton, S Blair, JA Busam, S Forstner, J Glance, G Green, A Kawata, ... Political behavior 42, 1073-1095, 2020 | 725* | 2020 |
| Primary and metastatic cutaneous melanomas express ALK through alternative transcriptional initiation KJ Busam, RE Vilain, T Lum, JA Busam, TJ Hollmann, RPM Saw, DC Coit, ... The American journal of surgical pathology 40 (6), 786-795, 2016 | 57 | 2016 |
| Ancestry inference using principal component analysis and spatial analysis: a distance-based analysis to account for population substructure J Byun, Y Han, IP Gorlov, JA Busam, MF Seldin, CI Amos BMC genomics 18, 1-12, 2017 | 51 | 2017 |
| Cost-effectiveness of DPYD genotyping prior to fluoropyrimidine-based adjuvant chemotherapy for colon cancer GA Brooks, S Tapp, AT Daly, JA Busam, ANA Tosteson Clinical colorectal cancer 21 (3), e189-e195, 2022 | 46 | 2022 |
| seXY: a tool for sex inference from genotype arrays DC Qian, JA Busam, X Xiao, TA O’Mara, RA Eeles, FR Schumacher, ... Bioinformatics 33 (4), 561-563, 2017 | 5 | 2017 |
| ChatGPT as a source of information for bariatric surgery patients: a comparative analysis of accuracy and comprehensiveness between GPT-4 and GPT-3.5 JS Samaan, N Rajeev, WH Ng, N Srinivasan, JA Busam, YH Yeo, ... Obesity Surgery 34 (5), 1987-1989, 2024 | 4 | 2024 |
| Cost effectiveness of DPYD genotyping to screen for dihydropyrimidine dehydrogenase (DPD) deficiency prior to adjuvant chemotherapy for colon cancer. GA Brooks, S Tapp, AT Daly, J Busam, ANA Tosteson Journal of Clinical Oncology 39 (3_suppl), 55-55, 2021 | 4 | 2021 |
| The rise of private equity in gastroenterology practices JA Busam, ED Shah Gastroenterology & Hepatology 19 (5), 264, 2023 | 2 | 2023 |
| what is needed to achieve success in developing diagnostic technologies for patients with gastrointestinal motility disorders‐past and present. JA Busam, ED Shah Alimentary Pharmacology & Therapeutics 56, 2022 | 1 | 2022 |
| Venture Capital in Retreat: Funding Trends in Gastroenterology Over the Past Decade JA Busam, ED Shah Clinical Gastroenterology and Hepatology 23 (1), 11-13, 2025 | | 2025 |
| Revisiting Meta-analyses of Placebo Response in Drug Trials for Irritable Bowel Syndrome: A Call to Disclose Excipients JA Busam, A Rezaie, M Pimentel Clinical Gastroenterology and Hepatology 22 (12), 2540-2541. e1, 2024 | | 2024 |
| Tu1650 CHANGES IN ANTI-VINCULIN ANTIBODIES OVER TIME CORRELATE WITH SYMPTOM IMPROVEMENT IN IRRITABLE BOWEL SYDROME (IBS) E Sharabi, JA Busam, K Mathur, A Rezaie, R Mathur, A Hosseini, ... Gastroenterology 166 (5), S-1364-S-1365, 2024 | | 2024 |
Katherine ClaytonPostdoc, Stanford UniversityGeverifieerd e-mailadres voor stanford.edu
